Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (9): 985-992.doi: 10.3969/j.issn.1000-6621.2019.09.013
• Original Articles • Previous Articles Next Articles
Han YANG,Huan LI,Jun XI,Ai-fang LI,Ji-ru XU()
Received:
2019-05-06
Online:
2019-09-10
Published:
2019-09-06
Contact:
Ji-ru XU
E-mail:xujiru@mail.xjtu.edu.cn
Han YANG,Huan LI,Jun XI,Ai-fang LI,Ji-ru XU. Fingerprint analysis of gut microbiota by denaturing gradient gel electrophoresis in newly diagnosed tuberculosis patients[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 985-992. doi: 10.3969/j.issn.1000-6621.2019.09.013
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.09.013
肠道菌群(属/种) | 对照组(242株) | 结核组(199株) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
菌株数 | 构成比(%) | 菌株数 | 构成比(%) | |||
Bacteroides 属 | 179 | 73.96 | 158 | 79.40 | 1.79 | 0.215 |
Bacteroides chinchillae | 0 | 0.00 | 7 | 3.52 | 8.65 | 0.004 |
Bacteroides coprocola | 12 | 4.96 | 7 | 3.52 | 0.55 | 0.491 |
Bacteroides coprophilus | 8 | 3.31 | 0 | 0.00 | 6.70 | 0.009 |
Bacteroides dorei | 0 | 0.00 | 27 | 13.57 | 34.98 | <0.001 |
Bacteroides faecichinchillae | 0 | 0.00 | 7 | 3.52 | 8.65 | 0.004 |
Bacteroides faecis | 0 | 0.00 | 22 | 11.06 | 28.16 | <0.001 |
Bacteroides graminisolvens | 21 | 8.68 | 0 | 0.00 | 18.13 | <0.001 |
Bacteroides helcogenes | 2 | 0.83 | 0 | 0.00 | 1.65 | 0.504 |
Bacteroides koreensis | 0 | 0.00 | 6 | 3.02 | 7.40 | 0.080 |
Bacteroides kribbi | 0 | 0.00 | 18 | 9.05 | 22.82 | <0.001 |
Bacteroides mediterraneensis | 2 | 0.83 | 0 | 0.00 | 1.65 | 0.504 |
Bacteroides plebeius | 6 | 2.48 | 0 | 0.00 | 5.00 | 0.035 |
Bacteroides sp | 0 | 0.00 | 5 | 2.51 | 6.15 | 0.018 |
Bacteroides stercoris | 0 | 0.00 | 10 | 5.03 | 12.44 | <0.001 |
Bacteroides thetaiotaomicron | 14 | 5.79 | 0 | 0.00 | 11.89 | <0.001 |
Bacteroides uniformis JCM5828 | 51 | 21.07 | 0 | 0.00 | 47.42 | <0.001 |
Bacteroides vulgatus | 63 | 26.03 | 42 | 21.11 | 1.46 | 0.261 |
Bacteroides xylanisolvens | 0 | 0.00 | 7 | 3.52 | 8.65 | 0.004 |
Prevotella属 | 59 | 24.38 | 18 | 9.04 | 17.82 | <0.001 |
Romboutsia lituseburensis 属 | 2 | 0.83 | 0 | 0.00 | 1.65 | 0.504 |
Saccharicrinis marinus 属 | 2 | 0.83 | 0 | 0.00 | 1.65 | 0.504 |
Uncultured bacterium 属 | 0 | 0.00 | 23 | 11.56 | 29.51 | <0.001 |
Uncultured bacterium 16sms157-2b03 | 0 | 0.00 | 2 | 1.01 | 2.44 | 0.203 |
Uncultured bacterium 218004-1-114 | 0 | 0.00 | 3 | 1.51 | 3.67 | 0.091 |
Uncultured bacterium denovo9345_591_35209 | 0 | 0.00 | 2 | 1.01 | 2.44 | 0.203 |
Uncultured bacterium G11_1_2c12_ | 0 | 0.00 | 4 | 2.01 | 4.91 | 0.041 |
Uncultured bacterium OTU561 | 0 | 0.00 | 2 | 1.01 | 2.44 | 0.203 |
Uncultured bacterium OTU939 16S | 0 | 0.00 | 3 | 1.51 | 3.67 | 0.091 |
Uncultured bacterium YO00054E08 | 0 | 0.00 | 5 | 2.51 | 6.15 | 0.018 |
Uncultured Bacteroidetes bacterium | 0 | 0.00 | 2 | 1.01 | 2.44 | 0.203 |
[1] | 王晖, 康迪, 周学东 , 等. 微生态调节技术在感染性疾病预防中的应用. 华西口腔医学杂志, 2018,36(5):564-567. |
[2] | Isolauri E . Microbiota and obesity. Nestle Nutr Inst Workshop Ser, 2017,88:95-105. |
[3] | Fang H, Li D, Kang J , et al. Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B12. Nat Commun, 2018,9(1):4917. |
[4] | Harmsen HJ, de Goffau MC . The human gut microbiota. Adv Exp Med Biol, 2016,902:95-108. |
[5] | Rautava S . Microbial composition of the initial colonization of newborns. Nestle Nutr Inst Workshop Ser, 2017,88:11-21. |
[6] | Tennyson CA, Friedman G . Microecology, obesity, and probiotics. Curr Opin Endocrinol Diabetes Obes, 2008,15(5):422-427. |
[7] | Chassaing B, Raja SM, Lewis JD , et al. Colonic microbiota encroachment correlates with dysglycemia in humans. Cell Mol Gastroenterol Hepatol, 2017,4(2):205-221. |
[8] | Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquín AJ , et al. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res, 2017,2017:4835189. |
[9] | 陈硕, 聂汉祥, 刘琳琳 , 等. 肠道菌群与支气管哮喘. 国际呼吸杂志, 2018,38(2):129-132. |
[10] | Gopalakrishnan V, Spencer CN, Nezi L , et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 2018,359(6371):97-103. |
[11] | Matson V, Fessler J, Bao R , et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science, 2018,359(6371):104-108. |
[12] | Routy B, Le Chatelier E, Derosa L , et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 2018,359(6371):91-97. |
[13] | Maji A, Misra R, Dhakan DB , et al. Gut microbiome contri-butes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol, 2018,20(1):402-419. |
[14] | Khan N, Vidyarthi A, Nadeem S , et al. Alteration in the gut microbiota provokes susceptibility to tuberculosis. Front Immunol, 2016,7:529. |
[15] | Kaufmann SHE . Indole propionic acid: a small molecule links between gut microbiota and tuberculosis. Antimicrob Agents Chemother, 2018, 62(5).pii:e00389-18. |
[16] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[17] | Li B, Yao Q, Zhu H . Approach to analyze the diversity of myxobacteria in soil by semi-nested PCR-denaturing gradient gel electrophoresis (DGGE) based on taxon-specific gene. PLoS One, 2014,9(10):e108877. |
[18] | Yasuhara M, Hunt G, Cronin TM , et al. Temporal latitudinal-gradient dynamics and tropical instability of deep-sea species diversity. Proc Natl Acad Sci U S A, 2009,106(51):21717-21720. |
[19] | Pearl JE, Das M, Cooper AM . Immunological roulette: Luck or something more? Considering the connections between host and environment in TB. Cell Mol Immunol, 2018,15(3):226-232. |
[20] | Luo M, Liu Y, Wu P , et al. Alternation of gut microbiota in patients with pulmonary tuberculosis. Front Physiol, 2017,8:822. |
[21] | Sandberg J, Kovatcheva-Datchary P, Björck I , et al. Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics. Eur J Nutr, 2019,58(6):2365-2376. |
[22] | Kovatcheva-Datchary P, Nilsson A, Akrami R , et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab, 2015,22(6):971-982. |
[23] | Sood U, Bajaj A, Kumar R , et al. Infection and microbiome: impact of tuberculosis on human gut microbiome of indian cohort. Indian J Microbiol, 2018,58(1):123-125. |
[24] | Namasivayam S, Maiga M, Yuan W , et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome, 2017,5(1):71. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||